Skip to content

Effect of Nava Kashaya Ghana Vati with Prapunnatadi Lepa in relieving signs and symptoms in patients of Dadru Kushta (Tinea Corporis)

A Randomized Comparative Clinical Study to Evaluate the Efficacy of Nava Kashaya Ghana Vati with Prapunnatadi Lepa and Triphaladi Gutika with Aragwadha Lepa in the Management of Dadru Kushta with special reference to Tinea Corporis - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/07/070503
Enrollment
40
Registered
2024-07-12
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B354- Tinea corporis

Interventions

None listed

Sponsors

BVVS Ayurved Medical College and Hospital Bagalkot
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed case of Dadru Kushta Patients with the age group between 18-60 years of either sex

Exclusion criteria

Exclusion criteria: Patients associated with other types of Kushta Systemic disorders like uncontrolled DM, HTN and autoimmune diseases which interfere with the course of the treatment Tinea corporis associated with other types of tinea infection and other skin diseases Pregnancy and Lactation

Design outcomes

Primary

MeasureTime frame
To assess subjective and objective parameters Itching, Erythema, Burning sensation, Pustule / vesicle, Dryness, Circular elevated lesions, size of lesions and number of lesionsTimepoint: 30 days

Secondary

MeasureTime frame
To assess subjective & objective parameters, Itching, Erythema, Burning sensation, Pustule / vesicle, Dryness, Circular elevated lesions, size of lesions & number of lesionsTimepoint: 10th 20th day

Countries

India

Contacts

Public ContactDr Sunilkumar M Chabanur

BVVS Ayurved Medical College and Hospital Bagalkot

drsunilkumar09@gmail.com9740878703

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026